Dr. Daniel H. Sterman - Mesothelioma Doctor - Associate Professor of Medicine
University of Pennsylvania Medical Center, Pulmonary, Allergy & Critical Care Division
833 West Gates Building
Call us at (888) 360-4215 to speak with a mesothelioma paralegal
3400 Spruce Street
Philadelphia, Pennsylvania 19104
Phone: 215.614.0984
Fax: 215.662.3226
Email Address: sterman@mail.med.upenn.edu
Dr. Daniel H. Sterman is an Associate Professor of Medicine, Associate Professor of Medicine in Surgery, Director of the PENN Interventional Pulmonology Program, and Clinical Director of the Thoracic Oncology Gene Therapy Program at the Center of Lung Cancer and Related Disorders at the University of Pennsylvania Medical Center in Philadelphia, Pennsylvania. He joined the faculty at the University of Pennsylvania Medical Center in 1997 as Assistant Professor of Medicine in the Pulmonary Division. He is board certified in Critical Care Medicine, Internal Medicine, and Pulmonary Medicine.
Dr. Sterman’s clinical interests include the treatment of thoracic malignancies, and unique technologies in Interventional Pulmonology. His research interests include: conducting clinical trials of gene therapy and vaccine therapy for lung cancer, mesothelioma, and other pleural malignancies, as well as in the translation of laboratory discoveries from “bench to bedside.”
Dr. Sterman received his A.B in European History in 1985 from Brown University in Providence, Rhode Island. He completed his medical degree in 1989 at Cornell University School of Medicine in New York, NY. Dr. Sterman completed his Internship and Residency in Internal Medicine at the Hospital of the University of Pennsylvania in Philadelphia from 1989-1992. He also completed an Instructorship in Emergency Medicine at the Hospital of the University of Pennsylvania from 1992-1993. He spent two years, from 1993-1995, at the University of Pennsylvania Medical Center where he completed his Pulmonary and Critical Care Fellowship as well as his Interventional Pulmonology Fellowship at the Pennsylvania Hospital/Section of General Thoracic Surgery.
Dr. Sterman began his Research Training Fellowship in 1995 at the Thoracic Oncology Research Laboratory at the University of Pennsylvania Medical Center. He completed this Fellowship in 1996. Today, Dr. Sterman has advanced training in: pleuroscopy, percutaneous tracheotomy, flexible and rigid bronchoscopy, endobronchial ultrasound (radial and convex probe), balloon bronchoplasty, auto-fluorescence bronchoscopy (LIFE), endobronchial stent placement (metal, hybrid, and silicone), endobronchial brachytherapy, photodynamic therapy, transbronchial needle aspiration/biopsy, and bronchoscopic electrosurgery (including APC).
Dr. Sterman is the lead clinical investigator in the multidisciplinary Thoracic Oncology Research Group at the University of Pennsylvania, he is the sponsor and Principal Investigator of the ongoing Ad.IFN-beta gene therapy trial aimed at cancer patients with mesothelioma and metastatic pleural disease, and he has led many other industry-sponsored cancer clinical trials.